Novo Nordisk Forges Ahead with Oral Wegovy and Weekly Insulin Amid CagriSema Device Study Withdrawal
Novo Nordisk is executing a multi-front strategy to defend its dominance in the obesity and diabetes markets, rolling…
Critical Metals Juggles Greenland Milestone and African Ambitions Amid Cash Constraints
Investors in Critical Metals PLC are weighing the promise of two major mining projects against a rapidly shrinking…
Amid Wegovy’s EU Endorsement, Novo Nordisk Grapples with a Rising Tide of Litigation and a Critical
EU approves higher-dose Wegovy, but CVS Caremark favors Eli Lilly drugs, legal claims over blindness risk mount, and…
Novo Nordisk’s Wegovy Pill Revenue Doubles Forecasts, Fuelling Optimism Amid Mixed Signals
Novo Nordisk’s oral Wegovy sales nearly double consensus to 2.26B DKK; stock rebounds 26% from low. Amazon expands…
Novo Nordisk’s Blood Disorder Breakthrough Offers a Lifeline Amid GLP-1 Gloom
Novo Nordisk’s etavopivat succeeds in Phase 3 sickle cell trial, cutting painful crises by 27%. This diversifies its…
European Lithium’s Share Buyback Launches Amid Greenland Permit Cliffhanger
European Lithium launches major share buyback, betting on its undervalued stock. The move’s success depends on a critical…
A Critical Quarter Amid Price Wars and Regulatory Shifts
Novo Nordisk’s Q1 2026 report faces scrutiny over Ozempic/Wegovy price cuts in India and US tariffs, balanced by…
A Litmus Test for Margins Amid Price Cuts
Novo Nordisk’s Q1 earnings will test profitability after global price cuts. EMA eases Wegovy storage rules, while generic…
New Drugs and a Massive Buyback Amid Market Pressure
Novo Nordisk’s share price hits 12-month low despite a major buyback and launch of Wegovy HD & oral…
A Defensive Move Amid Market Headwinds
Novo Nordisk launches a major share buyback despite its first revenue drop in 25 years, balancing challenges with…
Novo Nordisk Launches Aggressive Pricing Strategy for Wegovy Amid Restructuring
Novo Nordisk introduces a $249/month Wegovy subscription to boost patient loyalty and undercut Eli Lilly, while cutting 400…
European Lithium Maintains Stake in Greenland Venture Amid Regulatory Review
Audit confirms European Lithium’s 7.5% ownership in Tanbreez, Greenland. Critical Metals Corp plans to increase stake to 92.5%,…